Arpa Garay - 03 May 2022 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role: SVP Human Health Global Mktg.
Signature: /s/ Kelly E. W. Grez, as attorney-in-fact for Arpa Garay
Issuer symbol: MRK
Transactions as of: 03 May 2022
Net transactions value: +$56,441
Form type: 4
Filing time: 05 May 2022, 17:24:52 UTC
Previous filing: 03 May 2022
Next filing: 29 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRK	Common Stock	Options Exercise	$79,000	+907	+62%	$87.10	2,368	04 May 2022	Direct
transaction	MRK	Common Stock	Tax liability	$22,559	-259	-11%	$87.10	2,109	04 May 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRK	Restricted Stock Unit	Options Exercise	$0	-907	-33%	$0.000000	1,819	04 May 2022	Common Stock	907		Direct	F2, F3
transaction	MRK	Stock Option (Right to Buy)	Award	$0	+21,359		$0.000000	21,359	03 May 2022	Common Stock	21,359	$87.10	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Holdings include shares acquired in dividend reinvestment transactions.
F2	Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3	These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
F4	The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.